Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ADC Therapeutics SA (ADCT) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

ADC Therapeutics SA and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. ADC Therapeutics SA and Tonix Pharmaceuticals Holding Corp. are of similar size ($166.4M and $164.7M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against 3.03%. ADC Therapeutics SA has the higher net margin (−121.8% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 16 metrics below, ADC Therapeutics SA leads on 12 and Tonix Pharmaceuticals Holding Corp. on 4.

Valuation

Metric ADCT TNXP Biotechnology median
P/E n/m n/m 7.88
P/S 2.47 5.64 11.47
P/B n/m 0.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.03 0.74
EV/Sales 1.19 (0.16) 10.73
Earnings yield (51.97%) (134.34%) (28.84%)
Free cash flow yield (51.67%) (96.39%) (23.03%)

Profitability

Metric ADCT TNXP Biotechnology median
Gross margin 88.86% 83.83% 65.16%
Operating margin (125.08%) (568.43%) 0.00%
Net margin (121.77%) (548.64%) 0.00%
Free cash flow margin (127.72%) (543.29%) 0.00%
Return on equity 45.35% (81.82%) (57.72%)
Return on assets (32.25%) (72.34%) (49.22%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric ADCT TNXP Biotechnology median
Revenue growth (TTM) 3.03% 196.02% 5.64%
EPS growth (last fiscal year) 30.86% 91.75% —
Revenue growth, 5-year CAGR 103.35% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT TNXP Biotechnology median
Debt to equity (0.51) 0.00 0.00
Current ratio 3.03 6.61 4.73
Net debt to EBITDA 1.22 1.68 0.96

Dividend

Metric ADCT TNXP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADCT TNXP Biotechnology median
Market cap 164.69m 166.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack